1. Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer. Issue 1 (24th May 2020) Authors: Marliot, Florence; Chen, Xiaoyi; Kirilovsky, Amos; Sbarrato, Thomas; El Sissy, Carine; Batista, Luciana; Van den Eynde, Marc; Haicheur-Adjouri, Nacilla; Anitei, Maria-Gabriela; Musina, Ana-Maria; Scripcariu, Viorel; Lagorce-Pagès, Christine; Hermitte, Fabienne; Galon, Jérôme; Fieschi, Jacques; Pa... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 7 (July 2022) Authors: Antoniotti, Carlotta; Rossini, Daniele; Pietrantonio, Filippo; Catteau, Aurélie; Salvatore, Lisa; Lonardi, Sara; Boquet, Isabelle; Tamberi, Stefano; Marmorino, Federica; Moretto, Roberto; Ambrosini, Margherita; Tamburini, Emiliano; Tortora, Giampaolo; Passardi, Alessandro; Bergamo, Francesca; Kas... Journal: Lancet oncology Issue: Volume 23:Issue 7(2022) Page Start: 876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗